The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease

Journal of Lipid Research

Volumn 50, Issue 2, 2009, Pages 334-341

  Silbernagel, Guenther ^a   Fauler, Guenter ^b   Renner, Wilfried ^b   Landl, Eva M ^b   Hoffmann, Michael M ^c   Winkelmann, Bernhard R ^d   Boehm, Bernhard O ^e   März, Winfried ^b,f,g  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Cardiology Group Frankfurt Sachsenhausen   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g SYNLAB ACADEMY   (Germany)

Author keywords

Campesterol; Cholestanol; Cholesterol absorption; Cholesterol synthesis; Lathosterol; Phytosterols; Sitosterol

Indexed keywords

APOLIPOPROTEIN E; CAMPESTEROL; CHOLESTANOL; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LATHOSTEROL; PHYTOSTEROL; SITOSTEROL; DRUG DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SITOSTEROL DERIVATIVE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; BLOOD; METABOLISM; MIDDLE AGED; RADIOGRAPHY;

AGED; CHOLESTANOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOSTEROLS; SITOSTEROLS;

EID: 64749098665     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P800013-JLR200     Document Type: Article

References (54)

1. Wilson, P. W. F., R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel. 1998. Prediction of coronary heart disease using risk factor categories. Circulation. 97: 1837-1847.
2. Ostlund, R., Jr. 2002. Phytosterols in human nutrition. Annu. Rev. Nutr. 22: 533-549.
3. Wilund, K. R., L. Yu, F. Xu, G. Vega, S. Grundy, J. C. Cohen, and H. H. Hobbs. 2004. Plant sterol levels are not associated with atherosclerosis in mice and men. Arterioscler. Thromb. Vasc. Biol. 24: 2326-2332.
4. Bhattacharyya, A., and W. E. Connor. 1974. β-Sitosterolaemia and xanthomatosis. A newly described lipid storage disease in two sisters. J. Clin. Invest. 53: 1033-1043.
5. Salen, G., I. Horak, M. Rothkopf, J. L. Cohen, J. Speck, G. S. Tint, V. Shore, B. Dayal, T. Chen, and S. Shefer. 1985. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolaemia with xanthomatosis. J. Lipid Res. 26: 1126-1133.
6. Berge, K. E., H. Tian, G. A. Graf, L. YU, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H. H. Hobbs. 2000. Accumulation of dietary cholesterol in sitosterolaemia caused by mutations in adjacent ABC transporters. Science. 290: 1771-1775.
7. Lee, M. H., K. Lu, S. Hazard, H. Yu, S. Shulenin, H. Hidaka, H. Kojima, R. Allikmets, N. Sakuma, R. Pegoraro, et al. 2001. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27: 79-83.
8. Glueck, C. J., J. Speirs, T. Tracy, P. Streicher, E. Illig, and J. Vandegrift. 1991. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol and premature coronary heart disease in hyperphytosterolemic probands and their first degree relatives. Metabolism. 40: 842-848.
9. Sutherland, W. H. F., M. J. A. Williams, E. R. Nye, N. J. Restieaux, S. A. de Jong, and H. L. Walker. 1998. Associations of plasma noncholesterol sterol levels with severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 8: 386-391.
10. Sudhop, T., B. M. Gottwald, and K. von Bergmann. 2002. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 51: 1519-1521.
11. Assmann, G., P. Cullen, J. Erbey, D. R. Ramey, F. Kannenberg, and H. Schulte. 2006. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr. Metab. Cardiovasc. Dis. 16: 13-21.
12. Fassbender, K., D. Lutjohann, M. G. Dik, M. Bremmer, J. Koenig, S. Walter, Y. Liu, M. Letiembre, K. von Bergmann, and C. Jonker. 2008. Moderately elevated plant sterol levels are associated with reduced cardiovascular risk-The LASA study. Atherosclerosis. 196: 283-288.
13. Pinedo, S., M. N. Vissers, K. von Bergmann, M. D. Elharchaoui, D. Lutjohann, R. Luben, N. J. Wareham, J. J. P. Kastelein, K. T. Khaw, and S. M. Boeckholdt. 2007. Plasma levels of plant sterols and the risk of future coronary artery disease in apparently healthy men and women: The Prospective Epic-Norfolk Population Study. J. Lipid Res. 48: 139-144.
14. Rajaratnam, R. A., H. Gylling, and T. A. Miettinen. 2000. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J. Am. Coll. Cardiol. 35: 1185-1191.
15. Matthan, N. R., J. M. LaRoque, M. Pencina, R. B. D'Agostino, E. J. Schaefer, and A. H. Lichtenstein. 2005. Increased cholesterol absorption and decreased cholesterol synthesis characterize Framingham Offspring study participants with coronary heart disease. Circulation. 112: II-816-II-817 (abstract).
16. Strandberg, T. E., R. S. Tilvis, K. H. Pitkala, and T. A. Miettinen. 2006. Cholesterol and glucose metabolism and recurrent cardiovascular events among elderly. J. Am. Coll. Cardiol. 48: 708-714.
17. Weingr̈tner, O., D. Lütjohann, S. Ji, N. Weisshoff, F. List, T. Sudhop, K. von Bergmann, K. Gertz, J. König, H. J. Schäfers, et al. 2008. Vascular effects of diet supplementation with plant sterols. J. Am. Coll. Cardiol. 51: 1553-1561.
18. Miettinen, T. A., R. S. Tilvis, and Y. A. Kesämiemi. 1990. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 13: 20-31.
19. Miettinen, T. A., R. S. Tilvis, and Y. A. Kesaniemi. 1989. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism. 38: 136-140.
20. Gylling, H. 2004. Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia. Int. J. Clin. Pract. 58: 859-866.
21. Altmann, S. W., H. R. Davis, Jr., L. J. Zhu, X. Yao, L. M. Hoos, G. Tetzloff, S. P. Iyer, M. Maguire, A. Golovko, M. Zeng, et al. 2004. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science. 303: 1424-1431.
22. Gylling, H., M. Hallikainen, J. Pihlajamäki, J. Agren, M. Laakso, R. A. Rajaratnam, R. Rauramaa, and T. A. Miettinen. 2004. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J. Lipid Res. 45: 1660-1665.
23. Berge, K. E., K. von Bergmann, D. Lutjohann, R. Guerra, S. M. Grundy, H. H. Hobbs, and J. C. Cohen. 2002. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43: 486-494.
24. Cohen, J. C., A. Pertsemlidis, S. Fahmi, S. Esmail, G. L. Vega, S. M. Grundy, and H. Hobbs. 2006. Mul tiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc. Natl. Acad. Sci. USA. 103: 1810-1815.
25. Matthan, N. R., and A. H. Lichtenstein. 2004. Approaches to measuring cholesterol absorption in humans. Atherosclerosis. 174: 197-205.
26. Winkelmann, B. R., W. Marz, B. O. Boehm, R. Zotz, J. Hager, P. Hellstern, and J. Senges. LURIC Study Group (Ludwigshafen Risk and Cardiovascular Health). 2000. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics. 2 (1, Suppl 1): S1-S73.
27. Friesinger, G. C., E. E. Page, and R. S. Ross. 1970. Prognostic significance of coronary arteriography. Trans. Assoc. Am. Physicians. 83: 78-92.
28. American Diabetes Association. 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care. 29 (Suppl 1): S43-S48.
29. Stojakovic, T., C. Putz-Bankuti, G. Fauler, H. Scharnagl, M. Wagner, V. Stadlbauer, G. Gurakuqi, R. E. Stauber, W. März, and M. Trauner. 2007. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology. 46: 776-784.
30. Zivelin, A., N. Rosenberg, H. Peretz, Y. Amit, N. Kornbrot, and U. Seligsohn. 1997. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin. Chem. 43: 1657-1659.
31. Miettinen, T. A., T. E. Strandberg, and H. Gylling. 2000. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Arterioscler. Thromb. Vasc. Biol. 20: 1340-1346.
32. Simonen, P., H. Gylling, A. N. Howard, and T. A. Miettinen. 2000. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am. J. Clin. Nutr. 72: 82-88.
33. Gylling, H., and T. A. Miettinen. 1997. Cholesterol absorption, synthesis, and LDL metabolism in NIDDM. Diabetes Care. 20: 90-95.
34. Miettinen, T. A., and H. Gylling. 2007. Blood glucose and metabolism of cholesterol in coronary patients with and without simvastatin treatment. Clin. Chim. Acta. 379: 53-58.
35. Kesäniemi, Y. A., C. Ehnholm, and T. A. Miettinen. 1987. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest. 80: 578-581.
36. von Bergmann, K., D. Lütjohann, B. Lindenthal, and A. Steinmetz. 2003. Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype. J. Lipid Res. 44: 193-197.
37. Mellies, M. J., T. T. Ishikawa, C. J. Glueck, K. Bove, and J. Morrison. 1976. Phytosterols in aortic tissue in adults and infants. J. Lab. Clin. Med. 88: 914-921.
38. Miettinen, T. A., M. Railo, M. Lepäntalo, and H. Gylling. 2005. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J. Am. Coll. Cardiol. 45: 1794-1801.
39. Shepherd, J., S. M. Cobbe, I. Ford, C. G. Isles, A. R. Lorimer, P. W. MacFarlane, J. H. McKillop, and C. J. Packard. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333: 1301-1307.
40. Miettinen, T. A., H. Gylling, T. Strandberg, and S. Sarna. 1998. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. BMJ. 316: 1127-1130.
41. Herron, K. L., M. M. McGrane, D. Waters, I. E. Lofgren, R. M. Clark, J. M. Ordovas, and M. L. Fernandez. 2006. The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J. Nutr. 136: 1161-1165.
42. Sudhop, T., D. Lutjohann, A. Kodal, M. Igel, D. L. Tribble, S. Shah, I. Perevozskaya, and K. von Bergmann. 2002. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 106: 1943-1948.
43. Kastelein, J. J., F. Akdim, E. S. Stroes, A. H. Zwinderman, M. L. Bots, A. F. Stalenhoef, F. L. Visseren, E. J. Sijbrands, M. D. Trip, E. A. Stein, et al. 2008. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N. Engl. J. Med. 358: 1431-1443.
44. Law, M. 2000. Plant sterol and stanol margarines and health. BMJ. 320: 861-864.
45. Miettinen, T. A., P. Puska, H. Gylling, H. Vanhanen, and E. Vartiainen. 1995. Serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic random population. N. Engl. J. Med. 333: 1308-1312.
46. Weststrate, J. A., and G. W. Meijer. 1998. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 52: 334-343.
47. Plat, J., and R. P. Mensink. 2005. Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am. J. Cardiol. 96 (1A): 15D-22D.
48. Davis, H. R., Jr., D. S. Compton, L. Hoos, and G. Tetzloff. 2001. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 21: 2032-2038.
49. Jones, P. J. 2007. Ingestion of phytosterols is not potentially hazardous. J. Nutr. 137: 2485.
50. Fransen, H. P., N. de Jong, M. Wolfs, H. Verhagen, W. M. Verschuren, D. Lütjohann, K. von Bergmann, J. Plat, and R. P. Mensink. 2007. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J. Nutr. 137: 1301-1306.
51. Moghadasian, M. H., B. M. Mc Manus, D. V. Godin, B. Rodrigues, and J. J. Frolich. 1999. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action. Circulation. 99: 1733-1739.
52. Plat, J., I. Beugels, M. J. Gijbels, M. P. de Winter, and R. P. Mensink. 2006. Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. J. Lipid Res. 47: 2762-2771.
53. Raitakari, O. T., P. Salo, and M. Ahotupa. 2008. Carotid artery compliance in users of plant stanol ester margarine. Eur. J. Clin. Nutr. 62: 218-224.
54. Clarenbach, J. J., M. Reber, D. Lütjohann, K. von Bergmann, and T. Sudhop. 2006. The lipid-lowering effect of ezetimibe in pure vegetarians. J. Lipid Res. 47: 2820-2824.